Products - Menopause | Topic | NICE

Showing 3 products

Date | Title

Guidance programme: Technology appraisal guidanceRemove ‘Guidance programme: Technology appraisal guidance’ filter

Fezolinetant for treating vasomotor symptoms associated with the menopause [ID5071]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
21 May 2025
Estetrol for treating vasomotor symptoms associated with the menopause in people aged 40 to 65 ID4037
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Elinzanetant for treating vasomotor symptoms associated with menopause [ID6359]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC